Immunotherapy for hormone receptor-positive HER2-negative breast cancer

被引：1

作者：

Cardoso, Fatima ^{[1
]}

Hirshfield, Kim M. ^{[2
]}

Kraynyak, Kimberly A. ^{[2
]}

Tryfonidis, Konstantinos ^{[2
]}

Bardia, Aditya ^{[3
]}

机构：

[1] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[2] Merck & Co Inc, Rahway, NJ USA

[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA USA

来源：

NPJ BREAST CANCER | 2024年 / 10卷 / 01期

关键词：

PEMBROLIZUMAB PLUS CHEMOTHERAPY; TUMOR-INFILTRATING LYMPHOCYTES; ADJUVANT ENDOCRINE THERAPY; OPEN-LABEL; HIGH-RISK; NEOADJUVANT CHEMOTHERAPY; LOCALLY RECURRENT; NIVOLUMAB NIVO; TRIAL; PALBOCICLIB;

D O I：

10.1038/s41523-024-00704-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Additional therapies are needed to improve outcomes in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer. Research on the potential role of immunotherapy, particularly programmed cell death protein 1/programmed cell death ligand 1 inhibitors, is rapidly expanding in both the early and metastatic settings with some preliminary evidence suggesting benefit when used as part of combination therapy. Several ongoing phase 3 studies should help define their future role in treating these patients.

引用

页数：15

共 92 条

[1] New Advances in Targeted Therapy of HER2-Negative Breast Cancer [J].

An, Junsha ;

Peng, Cheng ;

Xie, Xiaofang ;

Peng, Fu .

FRONTIERS IN ONCOLOGY, 2022, 12

[2] Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer [J].

Andrahennadi, Samitha ;

Sami, Amer ;

Manna, Mita ;

Pauls, Mehrnoosh ;

Ahmed, Shahid .

CURRENT ONCOLOGY, 2021, 28 (03) :1803-1822

[3] Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial [J].

Bachelot, Thomas ;

Filleron, Thomas ;

Bieche, Ivan ;

Arnedos, Monica ;

Campone, Mario ;

Dalenc, Florence ;

Coussy, Florence ;

Sablin, Marie-Paule ;

Debled, Marc ;

Lefeuvre-Plesse, Claudia ;

Goncalves, Anthony ;

Reynier, Marie-Ange Mouret ;

Jacot, William ;

You, Benoit ;

Barthelemy, Philippe ;

Verret, Benjamin ;

Isambert, Nicolas ;

Tchiknavorian, Xavier ;

Levy, Christelle ;

Thery, Jean-Christophe ;

L'Haridon, Tifenn ;

Ferrero, Jean-Marc ;

Mege, Alice ;

Del Piano, Francesco ;

Rouleau, Etienne ;

Tran-Dien, Alicia ;

Adam, Julien ;

Lusque, Amelie ;

Jimenez, Marta ;

Jacquet, Alexandra ;

Garberis, Ingrid ;

Andre, Fabrice .

NATURE MEDICINE, 2021, 27 (02) :250-+

[4] A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer [J].

Barroso-Sousa, Romualdo ;

Krop, Ian E. ;

Trippa, Lorenzo ;

Tan-Wasielewski, Zhenying ;

Li, Tianyu ;

Osmani, Wafa ;

Andrews, Chelsea ;

Dillon, Deborah ;

Richardson, Edward T., III ;

Pastorello, Ricardo G. ;

Winer, Eric P. ;

Mittendorf, Elizabeth A. ;

Bellon, Jennifer R. ;

Schoenfeld, Jonathan D. ;

Tolaney, Sara M. .

CLINICAL BREAST CANCER, 2020, 20 (03) :238-245

[5] Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis [J].

Boman, Caroline ;

Zerdes, Ioannis ;

Martensson, Kira ;

Bergh, Jonas ;

Foukakis, Theodoros ;

Valachis, Antonios ;

Matikas, Alexios .

CANCER TREATMENT REVIEWS, 2021, 99

[6] Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials [J].

Braybrooke, Jeremy ;

Bradley, Rosie ;

Gray, Richard ;

Hills, Robert K. ;

Pan, Hongchao ;

Peto, Richard ;

Dodwell, David ;

McGale, Paul ;

Taylor, Carolyn ;

Aihara, Tomohiko ;

Anderson, Stewart ;

Yothers, Greg ;

Blum, Joanne ;

O'Shaughnessy, Joyce ;

Cardoso, Fatima ;

Chen, Xiaosong ;

Crown, John ;

Ejlertsen, Bent ;

Jensen, Maj-Britt ;

Friedl, Thomas W. P. ;

Janni, Wolfgang ;

Harbeck, N. ;

Mamounas, Eleftherios ;

Narui, K. ;

Nitz, Ulrike ;

Norton, Larry ;

Piccart, Martine ;

Robert, Nicholas ;

Shao, Zhi-Ming ;

Yu, Ke-Da ;

Slamon, Dennis ;

Sparano, Joseph ;

Watanabe, Toru ;

Bergh, Jonas ;

Swain, Sandra ;

Berry, R. ;

Boddington, C. ;

Bradley, R. ;

Clarke, M. ;

Davies, C. ;

Davies, L. ;

Dodwell, D. ;

Duane, F. ;

Evans, V. ;

Gay, J. ;

Gettins, L. ;

Godwin, J. ;

Gray, R. ;

Hills, R. K. ;

James, S. .

LANCET, 2023, 401 (10384) :1277-1292

[7] KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy (chemo), followed by adjuvant pembro or pbo plus endocrine therapy (ET) for early-stage high-risk ER+/HER2e breast cancer [J].

Cardoso, F. ;

McArthur, H. L. ;

Schmid, P. ;

Cortes, J. ;

Harbeck, N. ;

Telli, M. L. ;

Cescon, D. W. ;

O'Shaughnessy, J. ;

Fasching, P. ;

Shao, Z. ;

Loirat, D. ;

Park, Y. H. ;

Fernandez, M. E. Gonzalez ;

Liu, Z. ;

Yasojima, H. ;

Ding, Y. ;

Jia, L. ;

Karantza, V. V. ;

Tryfonidis, K. E. ;

Bardia, A. .

ANNALS OF ONCOLOGY, 2023, 34 :S1260-S1261

[8] 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) [J].

Cardoso, F. ;

Paluch-Shimon, S. ;

Senkus, E. ;

Curigliano, G. ;

Aapro, M. S. ;

Andre, F. ;

Barrios, C. H. ;

Bergh, J. ;

Bhattacharyya, G. S. ;

Biganzoli, L. ;

Boyle, F. ;

Cardoso, M-J ;

Carey, L. A. ;

Cortes, J. ;

El Saghir, N. S. ;

Elzayat, M. ;

Eniu, A. ;

Fallowfield, L. ;

Francis, P. A. ;

Gelmon, K. ;

Gligorov, J. ;

Haidinger, R. ;

Harbeck, N. ;

Hu, X. ;

Kaufman, B. ;

Kaur, R. ;

Kiely, B. E. ;

Kim, S-B ;

Lin, N. U. ;

Mertz, S. A. ;

Neciosup, S. ;

Offersen, B., V ;

Ohno, S. ;

Pagani, O. ;

Prat, A. ;

Penault-Llorca, F. ;

Rugo, H. S. ;

Sledge, G. W. ;

Thomssen, C. ;

Vorobiof, D. A. ;

Wiseman, T. ;

Xu, B. ;

Norton, L. ;

Costa, A. ;

Winer, E. P. .

ANNALS OF ONCOLOGY, 2020, 31 (12) :1623-1649

[9] Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Cardoso, F. ;

Kyriakides, S. ;

Ohno, S. ;

Penault-Llorca, F. ;

Poortmans, P. ;

Rubio, I. T. ;

Zackrisson, S. ;

Senkus, E. .

ANNALS OF ONCOLOGY, 2019, 30 (08) :1194-1220

[10]

Cardoso F, 2023, SAN ANTONIO BREAST C

← 1 2 3 4 5 6 7 8 9 10 →